SCHOTT Pharma AG & Co. KGaA - Asset Resilience Ratio

Latest as of September 2024: 0.23%

SCHOTT Pharma AG & Co. KGaA (1SXP) has an Asset Resilience Ratio of 0.23% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See financial flexibility index of SCHOTT Pharma AG & Co. KGaA to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

€3.25 Million

≈ $3.80 Million USD Cash + Short-term Investments

Total Assets

€1.44 Billion

≈ $1.69 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how SCHOTT Pharma AG & Co. KGaA's Asset Resilience Ratio has changed over time. See net asset quality index of SCHOTT Pharma AG & Co. KGaA to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down SCHOTT Pharma AG & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of SCHOTT Pharma AG & Co. KGaA.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€3.25 Million	0.23%
Total Liquid Assets	€3.25 Million	0.23%

Asset Resilience Insights

Limited Liquidity: SCHOTT Pharma AG & Co. KGaA maintains only 0.23% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

SCHOTT Pharma AG & Co. KGaA Industry Peers by Asset Resilience Ratio

Compare SCHOTT Pharma AG & Co. KGaA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd SHG:603087	Medical Instruments & Supplies	9.87%
Andon Health Co Ltd SHE:002432	Medical Instruments & Supplies	18.11%
Pegavision TW:6491	Medical Instruments & Supplies	17.14%
Tarsons Products Limited NSE:TARSONS	Medical Instruments & Supplies	0.47%
SciVision Biotech Inc TW:1786	Medical Instruments & Supplies	7.81%
Nyxoah BR:NYXH	Medical Instruments & Supplies	12.40%
I.Ceram SA PA:ALICR	Medical Instruments & Supplies	-1.61%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%

Annual Asset Resilience Ratio for SCHOTT Pharma AG & Co. KGaA (2022–2024)

The table below shows the annual Asset Resilience Ratio data for SCHOTT Pharma AG & Co. KGaA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	0.23%	€3.25 Million ≈ $3.80 Million	€1.44 Billion ≈ $1.69 Billion	+0.10pp
2023-06-30	0.12%	€1.53 Million ≈ $1.79 Million	€1.23 Billion ≈ $1.44 Billion	0.00pp
2022-06-30	0.12%	€1.49 Million ≈ $1.74 Million	€1.20 Billion ≈ $1.40 Billion	--

pp = percentage points

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$2.94 Billion

€2.51 Billion EUR

Market Cap Rank

#5729 Global

#884 in Germany

Share Price

€16.68

Change (1 day)

-0.12%

52-Week Range

€12.96 - €28.50

All Time High

€41.20